Ionis Pharmaceuticals, Inc. Increase (Decrease) in Other Operating Assets
Ionis Pharmaceuticals, Inc. (IONS) reported Increase (Decrease) in Other Operating Assets of $38.27 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-07-29
- Ionis Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $30.88M, a 203.59% increase year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $7.39M, a 40.24% decline year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$90.28M, a 609.98% decline year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $100.95M.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other operating assets for fiscal 2025 was $33.21M, a 28.44% increase from fiscal 2024.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other operating assets for fiscal 2024 was $25.86M, a 23.42% decline from fiscal 2023.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other operating assets for fiscal 2023 was $33.76M, a 23.97% increase from fiscal 2022.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other operating assets for fiscal 2022 was $27.23M, a 3005.47% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 6 month as first filed | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $30.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $38.27M 10-Q · filed 2026-07-29 | -$52.01M derived: sum of 3 quarters · filed 2026-07-29 | $48.94M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $7.39M 10-Q · filed 2026-04-29 | -$82.89M derived: sum of 2 quarters · filed 2026-04-29 | $18.07M derived: sum of 3 quarters · filed 2026-04-29 | $28.24M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | -$90.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.68M derived: sum of 2 quarters · filed 2026-02-26 | $20.85M derived: sum of 3 quarters · filed 2026-07-29 | $33.21M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $100.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $111.12M derived: sum of 2 quarters · filed 2026-07-29 | $123.49M 10-Q · filed 2025-10-29 | $141.19M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $10.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $22.54M 10-Q · filed 2026-07-29 | $40.24M derived: sum of 3 quarters · filed 2026-07-29 | $39.01M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $12.37M 10-Q · filed 2026-04-29 | $30.07M derived: sum of 2 quarters · filed 2026-04-29 | $28.84M derived: sum of 3 quarters · filed 2026-04-29 | $49.27M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $16.48M derived: sum of 2 quarters · filed 2026-02-26 | $36.91M derived: sum of 3 quarters · filed 2026-02-26 | $25.86M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $19.20M derived: sum of 2 quarters · filed 2025-10-29 | $8.15M 10-Q · filed 2025-10-29 | $23.59M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $20.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $9.38M 10-Q · filed 2025-07-30 | $24.82M derived: sum of 3 quarters · filed 2026-02-26 | $23.45M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$11.05M 10-Q · filed 2025-04-30 | -$13.38M 10-Q · filed 2024-05-07 | $4.39M derived: sum of 2 quarters · filed 2026-02-26 | $3.02M derived: sum of 3 quarters · filed 2026-02-26 | $28.03M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $15.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.07M derived: sum of 2 quarters · filed 2026-02-26 | $39.08M derived: sum of 3 quarters · filed 2026-02-26 | $33.76M 10-K · filed 2026-02-26 | $29.84M 10-K · filed 2024-02-21 | |||
| 2023-09-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $23.64M derived: sum of 2 quarters · filed 2024-11-06 | $18.32M 10-Q · filed 2024-11-06 | $44.57M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-06-30 | $25.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $19.70M 10-Q · filed 2024-08-01 | $45.94M derived: sum of 3 quarters · filed 2025-02-19 | $46.89M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-03-31 | -$5.31M 10-Q · filed 2024-05-07 | $20.93M derived: sum of 2 quarters · filed 2025-02-19 | $21.88M derived: sum of 3 quarters · filed 2025-02-19 | $14.70M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2022-12-31 | $26.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $27.20M derived: sum of 2 quarters · filed 2025-02-19 | $20.01M derived: sum of 3 quarters · filed 2025-02-19 | $27.23M 10-K · filed 2025-02-19 | $24.68M 10-K · filed 2023-02-22 | |||
| 2022-09-30 | $949.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$6.23M derived: sum of 2 quarters · filed 2023-11-02 | $988.00K 10-Q · filed 2023-11-02 | $12.22M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | -$7.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $39.00K 10-Q · filed 2023-08-09 | $11.27M derived: sum of 3 quarters · filed 2024-02-21 | $10.10M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $7.22M 10-Q · filed 2023-05-03 | $18.46M derived: sum of 2 quarters · filed 2024-02-21 | $17.28M derived: sum of 3 quarters · filed 2024-02-21 | $24.58M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | $11.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $10.06M derived: sum of 2 quarters · filed 2024-02-21 | $17.36M derived: sum of 3 quarters · filed 2024-02-21 | $877.00K 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | -$1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $6.12M derived: sum of 2 quarters · filed 2022-11-09 | -$10.36M 10-Q · filed 2022-11-09 | -$6.03M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $7.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$9.18M 10-Q · filed 2022-08-09 | -$4.85M derived: sum of 3 quarters · filed 2023-02-22 | $1.80M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | -$16.48M 10-Q · filed 2022-05-04 | -$12.15M derived: sum of 2 quarters · filed 2023-02-22 | -$5.50M derived: sum of 3 quarters · filed 2023-02-22 | $3.03M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $10.98M derived: sum of 2 quarters · filed 2023-02-22 | $19.51M derived: sum of 3 quarters · filed 2023-02-22 | $9.97M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $6.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $15.18M derived: sum of 2 quarters · filed 2021-11-03 | $5.65M 10-Q · filed 2021-11-03 | $26.93M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $8.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$1.00M 10-Q · filed 2021-08-04 | -$1.06M 10-Q · filed 2020-08-05 | $20.28M derived: sum of 3 quarters · filed 2022-02-25 | $37.29M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-03-31 | -$9.53M 10-Q · filed 2021-05-05 | $11.75M derived: sum of 2 quarters · filed 2022-02-25 | $28.75M derived: sum of 3 quarters · filed 2022-02-25 | $36.45M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $21.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $38.29M derived: sum of 2 quarters · filed 2022-02-25 | $45.98M derived: sum of 3 quarters · filed 2022-02-25 | $44.66M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $24.70M derived: sum of 2 quarters · filed 2020-11-04 | $23.38M 10-Q · filed 2020-11-04 | $26.15M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $7.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $6.37M 10-Q · filed 2020-08-05 | $9.15M derived: sum of 3 quarters · filed 2021-02-24 | $30.54M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | -$1.33M 10-Q · filed 2020-05-06 | -$1.80M 10-Q · filed 2019-05-09 | $1.45M derived: sum of 2 quarters · filed 2021-02-24 | $22.84M derived: sum of 3 quarters · filed 2021-02-24 | $39.44M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $24.17M derived: sum of 2 quarters · filed 2021-02-24 | $40.77M derived: sum of 3 quarters · filed 2021-02-24 | $29.35M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $21.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $37.99M derived: sum of 2 quarters · filed 2019-11-06 | $26.57M 10-Q · filed 2019-11-06 | $50.07M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $16.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $5.18M 10-Q · filed 2019-08-08 | $28.68M derived: sum of 3 quarters · filed 2020-03-02 | $24.17M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | -$11.42M 10-Q · filed 2019-05-09 | $12.08M derived: sum of 2 quarters · filed 2020-03-02 | $7.57M derived: sum of 3 quarters · filed 2020-03-02 | $32.87M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $23.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $19.00M derived: sum of 2 quarters · filed 2020-03-02 | $44.29M derived: sum of 3 quarters · filed 2020-03-02 | $58.37M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | -$4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $20.79M derived: sum of 2 quarters · filed 2018-11-06 | $34.87M 10-Q · filed 2018-11-06 | $33.24M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $25.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $39.37M 10-Q · filed 2018-08-07 | $37.74M derived: sum of 3 quarters · filed 2019-03-01 | $35.19M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $14.08M 10-Q · filed 2018-05-07 | $12.45M derived: sum of 2 quarters · filed 2019-03-01 | $9.90M derived: sum of 3 quarters · filed 2019-03-01 | $9.73M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | -$1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$4.18M derived: sum of 2 quarters · filed 2019-03-01 | -$4.35M derived: sum of 3 quarters · filed 2019-03-01 | -$1.60M 10-K · filed 2019-03-01 | -$1.66M 10-K · filed 2017-03-01 | |||
| 2016-09-30 | -$2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$2.72M derived: sum of 2 quarters · filed 2017-11-07 | $26.00K 10-Q · filed 2017-11-07 | $27.00K 10-Q · filed 2016-11-09 | -$9.04M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-06-30 | -$171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.58M 10-Q · filed 2017-08-09 | -$6.49M derived: sum of 3 quarters · filed 2018-02-28 | -$7.66M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-03-31 | $2.75M 10-Q · filed 2017-05-09 | -$6.32M derived: sum of 2 quarters · filed 2018-02-28 | -$7.49M derived: sum of 3 quarters · filed 2018-02-28 | $4.69M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2015-12-31 | -$9.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$10.23M derived: sum of 2 quarters · filed 2018-02-28 | $1.94M derived: sum of 3 quarters · filed 2018-02-28 | $4.39M 10-K · filed 2018-02-28 | $4.32M 10-K · filed 2016-02-26 | |||
| 2015-09-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $11.01M derived: sum of 2 quarters · filed 2016-11-09 | $13.46M 10-Q · filed 2016-11-09 | $13.26M 10-Q · filed 2015-11-09 | $13.97M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $12.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $14.63M 10-Q · filed 2016-08-09 | $14.63M 10-Q · filed 2015-08-05 | $15.14M derived: sum of 3 quarters · filed 2017-03-01 | $15.68M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $2.45M 10-Q · filed 2016-05-05 | $2.96M derived: sum of 2 quarters · filed 2017-03-01 | $3.51M derived: sum of 3 quarters · filed 2017-03-01 | $3.31M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $511.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.05M derived: sum of 2 quarters · filed 2017-03-01 | $854.00K derived: sum of 3 quarters · filed 2017-03-01 | $1.75M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $544.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $343.00K derived: sum of 2 quarters · filed 2015-11-09 | $1.24M 10-Q · filed 2015-11-09 | $795.00K derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | -$201.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $695.00K 10-Q · filed 2015-08-05 | $694.00K 10-Q · filed 2014-08-04 | $251.00K derived: sum of 3 quarters · filed 2016-02-26 | $1.29M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-03-31 | $896.00K 10-Q · filed 2015-05-05 | $452.00K derived: sum of 2 quarters · filed 2016-02-26 | $1.50M derived: sum of 3 quarters · filed 2016-02-26 | $386.00K derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | -$444.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $599.00K derived: sum of 2 quarters · filed 2016-02-26 | -$510.00K derived: sum of 3 quarters · filed 2016-02-26 | $1.09M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$66.00K derived: sum of 2 quarters · filed 2014-11-07 | $1.53M 10-Q · filed 2014-11-07 | |||||
| 2013-06-30 | -$1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $492.00K 10-Q · filed 2014-08-04 | ||||||
| 2013-03-31 | $1.60M 10-Q · filed 2014-05-06 | |||||||
| 2012-12-31 | -$279.00K 10-K · filed 2015-03-02 | |||||||
| 2011-12-31 | -$914.00K 10-K · filed 2014-03-03 | |||||||
| 2010-12-31 | $943.00K 10-K · filed 2013-02-28 | |||||||
| 2009-12-31 | $955.00K 10-K · filed 2012-02-29 | |||||||
| 2008-12-31 | $2.66M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |